Chatchakorn Eurtivong
Identification of anticancer agents based on the thieno[2,3-b]pyridine and 1H-pyrazole molecular scaffolds
Eurtivong, Chatchakorn; Reynisdóttir, Inga; Kuczma, Stephanie; Furkert, Daniel P.; Brimble, Margaret A.; Reynisson, Jóhannes
Authors
Inga Reynisdóttir
Stephanie Kuczma
Daniel P. Furkert
Margaret A. Brimble
Johannes Reynisson j.reynisson@keele.ac.uk
Abstract
Structural similarity search of commercially available analogues of thieno[2,3-b]pyridine and 1H-pyrazole derivatives, known anticancer agents, resulted in 717 hits. These were docked into the phosphoinositide specific-phospholipase C (PLC) binding pocket, the putative target of the compounds, to further focus the selection. Thirteen derivatives of the thieno[2,3-b]pyridines were identified and tested against the NCI60 panel of human tumour cell lines. The most active derivative 1 was most potent against the MDA-MB-435 melanoma cell line with GI50 at 30 nM. Also, it was found that a piperidine moiety is tolerated on the thieno[2,3-b]pyridine scaffold with GI50 = 296 nM (MDA-MB-435) for derivative 10 considerably expanding the structure activity relationship for the series. For the 1H-pyrazoles four derivatives were identified using the in silico approach and additionally ten were synthesised with various substituents on the phenyl moiety to extend the structural activity relationship but only modest anticancer activity was found.
Citation
Eurtivong, C., Reynisdóttir, I., Kuczma, S., Furkert, D. P., Brimble, M. A., & Reynisson, J. (2016). Identification of anticancer agents based on the thieno[2,3-b]pyridine and 1H-pyrazole molecular scaffolds. Bioorganic and Medicinal Chemistry, 24(16), 3521-3526. https://doi.org/10.1016/j.bmc.2016.05.061
Journal Article Type | Article |
---|---|
Acceptance Date | May 28, 2016 |
Online Publication Date | May 31, 2016 |
Publication Date | 2016-08 |
Deposit Date | Jun 12, 2023 |
Journal | Bioorganic & Medicinal Chemistry |
Print ISSN | 0968-0896 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 24 |
Issue | 16 |
Pages | 3521-3526 |
DOI | https://doi.org/10.1016/j.bmc.2016.05.061 |
Keywords | Organic Chemistry; Clinical Biochemistry; Drug Discovery; Pharmaceutical Science; Molecular Biology; Molecular Medicine; Biochemistry |
Additional Information | This article is maintained by: Elsevier; Article Title: Identification of anticancer agents based on the thieno[2,3-b]pyridine and 1H-pyrazole molecular scaffolds; Journal Title: Bioorganic & Medicinal Chemistry; CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.bmc.2016.05.061; Content Type: article; Copyright: © 2016 Elsevier Ltd. All rights reserved. |
You might also like
Accessing active fragments for drug discovery utilising nitroreductase biocatalysis.
(2024)
Journal Article